Literature DB >> 22701031

SLE with recurrent heart failure and a dermatological clue to another added possibility.

Luciano Candilio1, David D'Cruz, Divaka Perera.   

Abstract

A 36-year-old man with systemic lupus erythematosus (SLE) presented with chest pain, infero-lateral ST segment elevation on ECG and elevation of cardiac biomarkers and inflammatory markers. Coronary angiography ruled out obstructive coronary artery disease (CAD) but echocardiography showed impairment of regional and global left ventricular (LV) function. He was treated for SLE myocarditis but institution of aggressive immunosuppressant therapy only partially improved his condition, which followed a relapsing and remitting course in subsequent months, with progressive impairment of LV function. Cardiac MRI showed active inflammation and extensive transmural scarring. Endomyocardial biopsy (EMB) demonstrated patchy myocardial fibrosis and low-grade myocarditis and PCR assays excluded viral causes. The lack of response to immunosuppression and the detection of the sign of En coup de Sabre were suggestive of scleroderma as the underlying cause of the myocarditis.

Entities:  

Mesh:

Year:  2011        PMID: 22701031      PMCID: PMC3079525          DOI: 10.1136/bcr.08.2010.3283

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Linear childhood discoid lupus erythematosus following the lines of Blaschko: a case report with review of the linear manifestations of lupus erythematosus.

Authors:  J J Green; D J Baker
Journal:  Pediatr Dermatol       Date:  1999 Mar-Apr       Impact factor: 1.588

Review 2.  Myocarditis in systemic lupus erythematosus.

Authors:  Mevan Wijetunga; Stanley Rockson
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

Review 3.  Cardiac involvement in scleroderma.

Authors:  A Deswal; W P Follansbee
Journal:  Rheum Dis Clin North Am       Date:  1996-11       Impact factor: 2.670

4.  Localized scleroderma in childhood is not just a skin disease.

Authors:  Francesco Zulian; Cristina Vallongo; Patricia Woo; Ricardo Russo; Nicolino Ruperto; John Harper; Graciela Espada; Fabrizia Corona; Masha Mukamel; Richard Vesely; Elzbieta Musiej-Nowakowska; Jeff Chaitow; Joan Ros; Maria T Apaz; Valeria Gerloni; Henryka Mazur-Zielinska; Susan Nielsen; Susanne Ullman; Gerd Horneff; Carine Wouters; Giorgia Martini; Rolando Cimaz; Ronald Laxer; Balu H Athreya
Journal:  Arthritis Rheum       Date:  2005-09

Review 5.  The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.

Authors:  J G Coghlan; D Mukerjee
Journal:  Curr Opin Rheumatol       Date:  2001-11       Impact factor: 5.006

6.  Sclerodermic linear lupus panniculitis: report of two cases.

Authors:  A V Marzano; C Tanzi; R Caputo; E Alessi
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

7.  Mortality in primary and secondary myocarditis.

Authors:  Todd C Pulerwitz; Thomas P Cappola; G Michael Felker; Joshua M Hare; Kenneth L Baughman; Edward K Kasper
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

Review 8.  Myocarditis as a prognostic indicator in systemic lupus erythematosus.

Authors:  S Busteed; P Sparrow; C Molloy; M G Molloy
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

Review 9.  The heart as a target organ of immune injury.

Authors:  A Hastillo; H E Willis; M L Hess
Journal:  Curr Probl Cardiol       Date:  1991-06       Impact factor: 5.200

Review 10.  Heart disease in systemic sclerosis.

Authors:  D L Janosik; T G Osborn; T L Moore; D G Shah; R G Kenney; J Zuckner
Journal:  Semin Arthritis Rheum       Date:  1989-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.